One patient developed hypothyroidism due to autoimmune thyroiditis (anti-TPO levels > 1000 U/mL) during treatment with SSA; at T1, all 3 patients were adequately substituted with levothyroxine for more than 3 months. Here, TPO is linked to autoimmune thyroid disease.